Mono Pharmacare Limited
ListedSMEHealthcare · NSE
Incorporated in 1994, Mono Pharmacare Limited is engaged in the marketing and distribution of pharmaceutical products, offering a wide range of medicines and healthcare items including antibiotics, allergy & cough medicines, antifungals, nutraceuticals, pain relievers, antacids, antiemetics, and cardiac-diabetic medicines, along with cosmocare products. The company sells products under its brand “DLS Export”, which it acquired in 2022 for ₹609 lakhs to expand its product portfolio. As of February 28, 2023, Mono Pharmacare works with more than 168 pharmaceutical distributors & stockists and serves over 3,036 customers across retail pharmacy stores and wholesalers.
Price Band
₹26 – ₹28
Issue Size
₹14.84 Cr
Lot Size
4000 shares
GMP
₹2
+7.1%
Est. Listing
₹30
at current GMP
Subscribed
13.47x
overall
Open
28 Aug 2023
Close
30 Aug 2023
Allotment
4 Sep 2023
Refund
5 Sep 2023
Demat Credit
6 Sep 2023
Listing
7 Sep 2023
Last updated 12 days ago
Official Registrar Verification
Mono Pharmacare Limited Allotment Status
Designated Registrar: Bigshare Services Private Limited
Allotment Date
4 Sep 2023
Basis finalization
Refunds Initiate
5 Sep 2023
Mandate release
Demat Credit
6 Sep 2023
Shares in demat
Listing Debut
7 Sep 2023
Trading begins
How to Check Mono Pharmacare Limited IPO Allotment Status
- Click the Check on Registrar button above to visit Bigshare Services Private Limited's allotment portal.
- Select Mono Pharmacare Limited from the dropdown company list.
- Choose your lookup mode: PAN Number, Application Number, or DP Client ID.
- Enter your details accurately and solve the Captcha code.
- Click Submit / Search to view the number of shares applied and allotted to you.
About Mono Pharmacare Limited Public Issue & Market Profile
Mono Pharmacare Limited is bringing an initial public offering (IPO) in the Healthcare sector with an aggregate issue size of ₹14.84 Crores. The shares are offered at a price band of ₹26 to ₹28 per equity share on NSE. Currently, market analysts recommend evaluating the company's financial valuation, price-to-earnings (P/E) multiple, and peer comparison prior to submitting bids.
Public Issue & Allotment Procedure:
The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.
Official Allotment Timelines & Registrar Guidance:
Following the close of bidding on 2023-08-30, the basis of allotment is scheduled to be finalized on 2023-09-04. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.
Frequently Asked Questions
What if my name is not showing on the registrar portal?
Allotment records are updated in batches. If the status is not yet available, please wait a few hours until the basis of allotment is fully finalized.
How will I receive the refund if I don't get allotment?
Since funds are blocked under ASBA/UPI, the bank will automatically release the blocked hold on your funds upon receipt of revocation instructions from the sponsor bank.